PD-L1 (E1L3N) Antibody Kit (IHC)
Cancer Related Care
Information
PD-L1 (E1L3N) antibody kit (IHC) are used for in vitro qualitative testing of the protein expression of Programmed Death-Ligand 1 (PD-L1) in 4% neutral (phosphate buffered) formalin-fixed, paraffin-embedded (FFPE) NSCLC to assist with identifying lung cancer patients who can be treated with PD-1 inhibitor drug OPDIVO®(Bristol-Myers Squibb,Nivolumab). The PD-L1 IHC Kit (CE IVD) is a standardized IHC assay with all necessary components for 15, 30 or 50 tests in one kit.